🅇
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient.
Status
Recruiting
Phase
N/A
NCT ID
NCT06712563
Trial Summary
The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.
Lead Sponsor: AstraZeneca
Participants: ALL
Start Date: 2025-04-17
Primary Completion: 2026-12-14
Min Age: 18 Years
Eligibility Criteria
Inclusion Criteria: * Patients with moderate to severe COPD and initiating BGF treatment according to the local prescribing guidance and as per their treating physician's recommendation * Enrolled in on-going single-arm studies * Provided consent for secondary use of data Exclusion Criteria: * Did not provide consent for secondary use of data
Data sourced from ClinicalTrials.gov. Trial details may change — always check the primary source before clinical decisions.
More in Respiratory / COPD / Asthma
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III…
25 Mar 2026
A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in…
25 Mar 2026
Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function…
25 Mar 2026